Rupak Satpathi
@rupak2679
Patient Advocate in clinical research and Guidelines in Oncology , trained by National Cancer Grid and Patientengage . studied at Vidyasagar University..
National Cancer Institute of Kenya - Uniting Our Voices and Taking Action @NCIKenya oncodaily.com/blog/national-… #OncoDaily #Oncology #Cancer #Health #Medicine #MedTwitter #MedEd #MedOnc #MedNews
Admission to Integrated M.Sc.-Ph.D. Program in Life Sciences and Physical Sciences 2025-26 Adv no: BI/MSc-PhD/07/2025-26. For details, visit the link: jcbose.ac.in/uploads/ADVT/2… #PhD #integrated#Life sciences#Physical sciences
Just out! Current Risk stratification of all Plasma Cell Disorders. MGUS, SMM, Myeloma, Amyloidosis. We paid Open Access fees so you can download and read freely! Lots of Tables. Bookmark. @ZanwarSaurabh @myelomaMD @LeukemiaJnl Link: nature.com/articles/s4137…
🚨 NEWS 🚨 @EU_Commission has approved isatuximab in combination with bortezomib, lenalidomide, and dexamethasone (Isa-VRd) for the treatment of transplant-eligible newly diagnosed #MultipleMyeloma, based on data from the phase III GMMG-HD7 trial. Learn more:…
So what’s the position of DCGI regarding approval of Belantamab mafoditin for R/R Multiple Myeloma? Belantamab Mafodotin Combos Receive EU Approval for R/R Multiple Myeloma cancernetwork.com/view/belantama… via @@CancerNetwrk
Belantamab Mafodotin Combos Receive EU Approval for R/R Multiple Myeloma cancernetwork.com/view/belantama… via @@CancerNetwrk Bela is approved in Europe. It’s approved in Canada. Why can’t we have it in USA, FDA?
Andrea Gibson Refused to ‘Battle’ Cancer - The Atlantic theatlantic.com/books/archive/…
A very common occurance in LMC countries like my country, India. Where the access of testing along with very high testing cost deter many patients to take molecular testing Biomarker Testing in Advanced Cancer Still Lags Behind Guideline Recommendations medpagetoday.com/hematologyonco…
Artificial intelligence can be a handy tool when you need quick answers, but there are challenges when it comes to finding accurate medical information. Our experts break down how to navigate this in the ever-expanding world of AI: spr.ly/60164fIei #EndCancer
What is CAR-T? What are the side effects? When is it appropriate? What questions you should ask your treating doctor? And more Join us on 14th July 7.30pm IST as we speak with Dr. Hari Menon to demystify CAR-T so we can take #informeddecisions on this new treatment. #Unpacking
Unique opportunity to hone your knowledge & skills in cancer research methods - last date to apply for the @credoworkshop 15th Jul 2025 Organized by @CancerGridIndia Details at credo.ncgindia.org Apply at credo.ncgindia.org/apply (1/2)
Landmark achievement in cancer care!🛡️ India’s first high-dose 131-I MIBG therapy for neuroblastoma was successfully performed at ACTREC, Tata Memorial Centre, Navi Mumbai, on May 5, 2025. 🧵 (1/5)
Today is #WorldSickleCellDay. Let us take a moment to understand what it is, the causes, the symptoms
*Haldiram has advertised that it will only hire Hindi speakers, and will not hire Bengalis for any position from supervisor to salesman. Boycott Haldiram. Who will do business in Bengal, sell goods to Bengalis, and will only hire Hindi speakers? #Boycotthaldiram